Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine to reduce pain from propofol injection
ChiCTR2200061856Phase 4Not yet recruiting
- Sponsor
- Shandong Cancer Hospital
- Start
- Jun 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of esketamine in Neoplasm (2 arms), sponsored by Shandong Cancer Hospital. Primary endpoint: Pain score during propofol injection. Planned start Jun 2022; status: not yet recruiting.
02
Drugs
esketamine
03
Conditions
Neoplasm
Beyond the preview
Go deeper on ChiCTR2200061856.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2200061856.